Allicin reduces the production of α-toxin by Staphylococcus aureus

Staphylococcus aureus causes a broad range of life-threatening diseases in humans. The pathogenicity of this micro-organism is largely dependent upon its virulence factors. One of the most extensively studied virulence factors is the extracellular protein α-toxin. In this study, we show that allicin...

Full description

Saved in:
Bibliographic Details
Published inMolecules (Basel, Switzerland) Vol. 16; no. 9; pp. 7958 - 7968
Main Authors Leng, Bing-Feng, Qiu, Jia-Zhang, Dai, Xiao-Han, Dong, Jing, Wang, Jian-Feng, Luo, Ming-Jing, Li, Hong-En, Niu, Xiao-Di, Zhang, Yu, Ai, Yong-Xing, Deng, Xu-Ming
Format Journal Article
LanguageEnglish
Published Switzerland MDPI 15.09.2011
MDPI AG
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Staphylococcus aureus causes a broad range of life-threatening diseases in humans. The pathogenicity of this micro-organism is largely dependent upon its virulence factors. One of the most extensively studied virulence factors is the extracellular protein α-toxin. In this study, we show that allicin, an organosulfur compound, was active against S. aureus with MICs ranged from 32 to 64 μg/mL. Haemolysis, Western blot and real-time RT-PCR assays were used to evaluate the effects of allicin on S. aureus α-toxin production and on the levels of gene expression, respectively. The results of our study indicated that sub-inhibitory concentrations of allicin decreased the production of α-toxin in both methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) in a dose-dependent manner. Furthermore, the transcriptional levels of agr (accessory gene regulator) in S. aureus were inhibited by allicin. Therefore, allicin may be useful in the treatment of α-toxin-producing S. aureus infections.
Bibliography:These authors contributed equally to this work.
ISSN:1420-3049
1420-3049
DOI:10.3390/molecules16097958